Nurix Therapeutics (NRIX.US) was first covered by Stephens & Co. with an incremental rating, with a target price of $20.00.
Nurix Therapeutics(NRIX.US)获Stephens & Co.首次覆盖，给予增持评级, 目标价20.00美元。
Nurix Therapeutics (NRIX.US) was first covered by Stephens & Co. with an incremental rating, with a target price of $20.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.